Cloning And Mutagenesis Market
According to Intent Market Research, the Cloning And Mutagenesis Market is expected to grow from USD 3.0 Billion in 2024-e at a CAGR of 9.4% to touch USD 5.1 Billion by 2030. The Cloning And Mutagenesis Market is dominated by key players such as Merck KGaA, Agilent Technologies Inc., New England Biolabs Inc., Takara Bio Inc., Promega Corporation, and QIAGEN N.V.